Tumor‐Microenvironment‐Responsive Cerium‐Enriched Copper Nanozyme with O2 Supply And Oxidative Stress Amplification for In Situ Disulfiram Chemotherapy And Chemodynamic Therapy Intensification

Abstract Traditional chemotherapy has faced tough challenges of systemic toxicity, hypoxia resistance, and inadequacy of monotherapy. Developing the tumor‐specific O 2 ‐supply‐enhanced chemotherapy without toxic drugs while combing other precise treatments will substantially improve therapeutic efficacy. Herein, we developed a CeO 2 ‐enriched CuO nanozyme with O 2 supply and oxidative stress amplification for tumor‐specific disulfiram (DSF) chemotherapy and intensified chemodynamic therapy by synergistic in situ “nontoxicity‐toxicity” activation. Notably, CeO 2 could not only act as a morphological “regulator”, but also serve as a cascaded enzyme‐mimetic catalyst via tumor‐microenvironment‐responsive cascaded‐logical programmable valence conversion. Once internalized inside tumor cells, the nanozyme could be degraded by lysosomal acidity to release nontoxic DSF and Cu 2+ , which would trigger in situ “Cu 2+ ‐DSF” chelation, generating a highly toxic Cu(DTC) 2 for in situ chemotherapy. Moreover, the enriched CeO 2 with catalase‐mimetic activity could decompose the endogenous H 2 O 2 into O 2 , which would relieve the hypoxia to enhance the chemotherapeutic efficacy. Furthermore, the simultaneously generated Ce 3+ could exert peroxidase‐mimetic activity to catalyze H 2 O 2 into hydroxyl radicals (•OH) for chemodynamic therapy. This Fenton‐like chemistry was accompanied by the regeneration of Ce 4+ , which could deplete the intracellular overproduced GSH to amplify the oxidative stress. Therefore, our nanozyme could provide an alternative to precise cancer treatment. This article is protected by copyright. All rights reserved